Wednesday, July 8, 2026

biotech · WHIM Syndrome · Neutropenias · XFOR

X4 Pharmaceuticals

X4 Pharmaceuticals trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.

61 N Beacon St, Boston, Massachusetts 02134, US HQ
2014 Founded
81 Employees
Public company Type
XFOR · NYSE Ticker
Company details
Status
Public
HQ
61 N Beacon St, Boston, Massachusetts 02134, US
Founded
2014
Employees
81
Programs
11
Drugs
6
Patents
16
Intelligence · Clinical Trials

X4 Pharmaceuticals clinical trials

Registry index of 13 ClinicalTrials.gov studies linked to X4 Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.

X4 Pharmaceuticals trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for X4 Pharmaceuticals.

  1. Mavorixafor, Mavorixafor Placebo Capsules — Phase 3

    Clinical update
  2. Mavorixafor, Placebo to Test IMP — Phase 3

    Clinical update
  3. Mavorixafor — Phase 1

    Clinical update
  4. X4P-001 — Phase 1

    Clinical update
  5. Mavorixafor — Phase 3

    Clinical update
  6. Mavorixafor — Phase 3

    Clinical update
  7. X4P-001 — Phase 2

    Clinical update
  8. X4P-001 — Phase 2

    Clinical update

Trial registry

13 studies